Nitinotes Surgical
Raz Bar-On is the CEO of Nitinotes, a company that develops robotic automated non-surgical suturing devices for treating obesity. Raz is also the owner of Bar-On R&D Ltd., specializing in medical devices. In the past, Raz served as the CEO of Gema Medical Ltd., where the company mapped the electro mechanical activity of the stomach for treating gastric motility disorders. Additionally, Raz was a co-founder of slimedics, which developed a minimally invasive intra gastric device for obesity treatment. With a background in mechanical engineering and a degree in business administration and entrepreneurship, Raz has held various positions in research and development in companies like Cappella Inc., MVT Multi vision technologies Ltd., and ARAN R&D Ltd.
Nitinotes Surgical
Nitinotes is a privately-held medical device company based in Caesarea, Israel that focuses on providing a safer and simpler suturing solution for endoscopic gastroplasty. Its flagship product, the EndoZip™, is an endoscopic robotic suturing system that has been backed by clinical success and prominent KOLs. By simplifying and speeding up the suturing process, EndoZip™ makes endoscopic gastroplasty a widely available, easy-to-perform procedure that offers an effective and minimally-invasive solution for more than 700 million patients with obesity class I & II for whom traditional bariatric surgery is not an option.